- Home
- MTVA vs ONMD Comparison
MTVA vs ONMD Comparison
Compare MTVA & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- ONMD
- Stock Information
- Founded
- MTVA 2014
- ONMD 2006
- Country
- MTVA United States
- ONMD United States
- Employees
- MTVA N/A
- ONMD N/A
- Industry
- MTVA
- ONMD
- Sector
- MTVA
- ONMD
- Exchange
- MTVA NYSE
- ONMD Nasdaq
- Market Cap
- MTVA 14.3M
- ONMD 12.8M
- IPO Year
- MTVA N/A
- ONMD N/A
- Fundamental
- Price
- MTVA $0.71
- ONMD $0.51
- Analyst Decision
- MTVA Strong Buy
- ONMD
- Analyst Count
- MTVA 2
- ONMD 0
- Target Price
- MTVA $7.50
- ONMD N/A
- AVG Volume (30 Days)
- MTVA 64.8K
- ONMD 318.8K
- Earning Date
- MTVA 08-13-2025
- ONMD 05-14-2025
- Dividend Yield
- MTVA N/A
- ONMD N/A
- EPS Growth
- MTVA N/A
- ONMD N/A
- EPS
- MTVA N/A
- ONMD N/A
- Revenue
- MTVA N/A
- ONMD $532,000.00
- Revenue This Year
- MTVA N/A
- ONMD N/A
- Revenue Next Year
- MTVA N/A
- ONMD N/A
- P/E Ratio
- MTVA N/A
- ONMD N/A
- Revenue Growth
- MTVA N/A
- ONMD N/A
- 52 Week Low
- MTVA $0.60
- ONMD $0.30
- 52 Week High
- MTVA $4.36
- ONMD $1.60
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- ONMD 47.81
- Support Level
- MTVA N/A
- ONMD $0.50
- Resistance Level
- MTVA N/A
- ONMD $0.57
- Average True Range (ATR)
- MTVA 0.00
- ONMD 0.05
- MACD
- MTVA 0.00
- ONMD -0.01
- Stochastic Oscillator
- MTVA 0.00
- ONMD 28.87
About MTVA METAVIA INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.